Li San-Zhong, Su Ning, Wu Shuang, Fei Xiao-Wei, He Xin, Zhang Jiu-Xiang, Wang Xiao-Hui, Zhang Hao-Peng, Bai Xiao-Guang, Cheng Guang, Fei Zhou
Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Department of Radiotherapy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Chin Neurosurg J. 2022 Dec 30;8(1):45. doi: 10.1186/s41016-022-00311-2.
Awake craniotomy (AC) has become gold standard in surgical resection of gliomas located in eloquent areas. The conscious sedation techniques in AC include both monitored anesthesia care (MAC) and asleep-awake-asleep (AAA). The choice of optimal anesthetic method depends on the preferences of the surgical team (mainly anesthesiologist and neurosurgeon). The aim of this study was to compare the difference in physiological and blood gas data, dosage of different drugs, the probability of switching to endotracheal intubation, and extent of tumor resection and dysfunction after operation between AAA and MAC anesthetic management for resection of gliomas in eloquent brain areas.
Two-hundred and twenty-five patients with super-tentorial tumor located in eloquent areas underwent AC from 2009 to 2021 in Xijing Hospital. Forty-one patients underwent AAA technique, and the rest one-hundred eighty-four patients underwent MAC technique. Anesthetic management, dosage of different drugs, intraoperative complications, postoperative outcomes, adverse events, extent of resection and motor, and sensory and language dysfunction after operation were compared between MAC and AAA.
There was no significant difference in gender, KPS score, MMSE score, glioma grade, type, and growth site between the patients in the two groups, except the older age of patients in MAC group than that in AAA group. During the whole process of operation, there were greater pulse pressure difference (P = 0.046), shorter operation time (P = 0.039), less dosage of remifentanil (P = 0.000), more dosage of dexmedetomidine (P = 0.013), more use of antiemetics (81%, P = 0.0067), lower use of vasoactive agent (45.1%, P = 0.010), and lower probability of conversion to general anesthesia (GA, P = 0.027) in MAC group than that in AAA group. Blood gas analysis showed that PetCO2 (P = 0.000), Glu concentration (P = 0.000), and PaCO2 (P = 0.000) were higher, but SPO2 (P = 0.002) and PaO2 (P = 0.000) were lower in MAC group than that in AAA group. In the postoperative recovery stage, compared with that of AAA group, the probability of dysfunction in MAC group at 1, 3, 5, and 7 days after operation was lower, which were 27.8% vs 53.6% (P = 0.003), 31% vs 68.3% (P = 0.000), 28.8% vs 63.4% (P = 0.000), and 25.6% vs 58.5% (P = 0.000), respectively.
Compared with AAA, it seems that MAC has more advantages in the management for resection of gliomas in eloquent brain areas, and MAC combined with multiple monitoring such as cerebral cortical mapping, neuronavigation, and ultrasonic detection is worthy of popularization for the resection of gliomas in eloquent brain areas.
清醒开颅手术(AC)已成为位于功能区的胶质瘤手术切除的金标准。AC中的清醒镇静技术包括监护麻醉(MAC)和睡-醒-睡(AAA)。最佳麻醉方法的选择取决于手术团队(主要是麻醉医生和神经外科医生)的偏好。本研究的目的是比较AAA和MAC麻醉管理在切除功能区脑胶质瘤时生理和血气数据、不同药物剂量、改为气管插管的概率、肿瘤切除范围以及术后功能障碍方面的差异。
2009年至2021年,西京医院225例幕上功能区肿瘤患者接受了AC。41例患者采用AAA技术,其余184例患者采用MAC技术。比较MAC和AAA在麻醉管理、不同药物剂量、术中并发症、术后结果、不良事件、切除范围以及术后运动、感觉和语言功能障碍方面的差异。
两组患者在性别、KPS评分、MMSE评分、胶质瘤分级、类型和生长部位方面无显著差异,但MAC组患者年龄比AAA组大。在整个手术过程中,MAC组的脉压差更大(P = 0.046)、手术时间更短(P = 0.039)、瑞芬太尼剂量更少(P = 0.000)、右美托咪定剂量更多(P = 0.013)、使用止吐药更多(81%,P = 0.0